The number of remotely monitored patients grew by 51 percent to 4.9 million in 2015, propelled by rising market acceptance in several key verticals. This number includes all patients enrolled in mHealth care programs in which connected medical devices are used as a part of the care regimen, but it doesn’t count personal health tracking devices. Berg Insight estimates that the number of remotely monitored patients will grow at a compound annual growth rate (CAGR) of 48.9 percent to reach 36.1 million by 2020.
Meanwhile, revenues are expected to reach 25.0 billion EUR at the end o 2020, growing at a CAGR of 32.1 percent from this year’s 6.2 billion EUR.
ResMed was especially successful in the sleep therapy segment with its new Air Solutions family of devices.The two main applications are monitoring of patients with implantable cardiac rhythm management (CRM) devices and monitoring of patients with sleep therapy devices. These two verticals accounted for 81 percent of all connected home medical monitoring systems this year. Telehealth is the third largest segment with 0.41 million connections at the end of 2015. All other device categories — including ECG, glucose level, medication adherence and others — stood for less than 0.2 million connections each at the end of the year.
ResMed was especially successful in the sleep therapy segment with its new Air Solutions family of devices that includes a cellular M2M module as standard and is supported by a range of health informatics software that enable healthcare organizations to provide better care more efficiently. The company has surpassed Medtronic and is now the world’s largest provider of connected healthcare solutions for remote patient monitoring.
Another landmark event in 2015 was that cellular connectivity surpassed PSTN and LAN as the most widely used connectivity technology for remote patient monitoring.
“Cellular continues to be the only technology that can be used to reliably connect every patient with their healthcare providers,” says Lars Kurkinen, Senior Analyst at Berg Insight.
An emerging alternative is that patients use their own mobile devices as health hubs. The bring your own device (BYOD) model can in theory be very cost-efficient as no dedicated hardware or subscriptions are needed, but accounted for less than two percent of all connections in 2015.
Mr. Kurkinen predicts that BYOD will be especially useful for patient-centric engagement programs in therapeutic areas such as diabetes and asthma that have younger patient demographics compared to many other chronic diseases.